Diarrhea Therapeutic Pipeline Review H1 2015 Market Research Report – New at ReportsnReports.com

Dallas, TX (PRWEB) January 31, 2015

The report “Diarrhea – Pipeline Review, H1 2015″ provides comprehensive information on the therapeutic development for diarrhea. Diarrhea describes loose, watery stools that occur more repeatedly than usual. The most common cause of diarrhea is the stomach flu. Eating or drinking food or water that contains certain types of bacteria or parasites can also lead to diarrhea. Diarrhea and related complications can cause severe ill health. The most significant cause of severe ill health is loss of water and electrolytes. Signs and symptoms of diarrhea include dehydration, failure to thrive and malnutrition, abdominal pain, borborygmi and perianal erythema. Diarrheal disease may have a negative impact on both physical fitness and mental development. Complete Report is Available @ http://ift.tt/1BIZi9Z.

It also reviews key players involved in the therapeutic development for diarrhea and special features on late-stage and discontinued projects. Companies discussed in this Diarrhea Pipeline Review H1 2015 report include A. Menarini Industrie Farmaceutiche Riunite Srl, Ache Laboratorios Farmaceuticos S/A, Actelion Ltd, Aegis Therapeutics, LLC, Assembly Biosciences, Inc., Chiesi Farmaceutici SpA, Chongqing Zhifei Biological Products Co., Ltd., Cosmo Pharmaceuticals S.p.A, Cubist Pharmaceuticals, Inc., DesignMedix, Inc., DiscoveryBiomed, Inc., Furiex Pharmaceuticals, Inc., GlycoVaxyn AG, GP Pharm, S.A., Helsinn Healthcare S.A., Intercept Pharmaceuticals, Inc., Ipsen S.A., Mucosis B.V., Napo Pharmaceuticals, Inc., Nippon Shinyaku Co., Ltd., Novartis AG, Paratek Pharmaceuticals, Inc., Pfizer Inc., Prokarium Ltd., Sanofi Pasteur SA, Scandinavian Biopharma Holding AB, Shire Plc, Sigmoid Pharma Limited, Summit Corporation plc, Syntiron LLC, and Ventria Bioscience.

The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. The report enhances decision making capabilities and helps to create effective counter strategies to gain the competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Purchase copy of this report @ http://ift.tt/16eidBz. (This is a premium report priced at US $ 2,000 for a single user License.)

Table of Contents

List of Tables



Number of Products under Development for Diarrhea, H1 2015



Number of Products under Development for Diarrhea – Comparative Analysis, H1 2015



Number of Products under Development by Companies, H1 2015



Number of Products under Development by Companies, H1 2015 (Contd..1)



Number of Products under Development by Companies, H1 2015 (Contd..2)



Number of Products under Investigation by Universities/Institutes, H1 2015



Comparative Analysis by Late Stage Development, H1 2015



Comparative Analysis by Clinical Stage Development, H1 2015



Comparative Analysis by Early Stage Development, H1 2015



Products under Development by Companies, H1 2015



Products under Development by Companies, H1 2015 (Contd..1)



Products under Development by Companies, H1 2015 (Contd..2)



Products under Investigation by Universities/Institutes, H1 2015



Diarrhea – Pipeline by A. Menarini Industrie Farmaceutiche Riunite Srl, H1 2015



Diarrhea – Pipeline by Ache Laboratorios Farmaceuticos S/A, H1 2015



Diarrhea – Pipeline by Actelion Ltd, H1 2015



Diarrhea – Pipeline by Aegis Therapeutics, LLC, H1 2015



Diarrhea – Pipeline by Assembly Biosciences, Inc., H1 2015



Diarrhea – Pipeline by Chiesi Farmaceutici SpA, H1 2015



Diarrhea – Pipeline by Chongqing Zhifei Biological Products Co., Ltd., H1 2015



Diarrhea – Pipeline by Cosmo Pharmaceuticals S.p.A, H1 2015



Diarrhea – Pipeline by Cubist Pharmaceuticals, Inc., H1 2015



Diarrhea – Pipeline by DesignMedix, Inc., H1 2015



Diarrhea – Pipeline by DiscoveryBiomed, Inc., H1 2015



Diarrhea – Pipeline by Furiex Pharmaceuticals, Inc., H1 2015



Diarrhea – Pipeline by GlycoVaxyn AG, H1 2015



Diarrhea – Pipeline by GP Pharm, S.A., H1 2015



Diarrhea – Pipeline by Helsinn Healthcare S.A., H1 2015



Diarrhea – Pipeline by Intercept Pharmaceuticals, Inc., H1 2015



Diarrhea – Pipeline by Ipsen S.A., H1 2015



Diarrhea – Pipeline by Mucosis B.V., H1 2015



Diarrhea – Pipeline by Napo Pharmaceuticals, Inc., H1 2015



Diarrhea – Pipeline by Nippon Shinyaku Co., Ltd., H1 2015



Diarrhea – Pipeline by Novartis AG, H1 2015



Diarrhea – Pipeline by Paratek Pharmaceuticals, Inc., H1 2015



Diarrhea – Pipeline by Pfizer Inc., H1 2015



Diarrhea – Pipeline by Prokarium Ltd., H1 2015



Diarrhea – Pipeline by Sanofi Pasteur SA, H1 2015



Diarrhea – Pipeline by Scandinavian Biopharma Holding AB, H1 2015



Diarrhea – Pipeline by Shire Plc, H1 2015



Diarrhea – Pipeline by Sigmoid Pharma Limited, H1 2015



Diarrhea – Pipeline by Summit Corporation plc, H1 2015



Diarrhea – Pipeline by Syntiron LLC, H1 2015



Diarrhea – Pipeline by Ventria Bioscience, H1 2015

Explore more reports on the Pharmaceuticals industry at http://ift.tt/1jix2lw.

About Us:



ReportsnReports.com is an online database of market research reports offering in-depth analysis of over 5,000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offers customized market research reports for multiple industries.

More Fitness Press Releases

The post Diarrhea Therapeutic Pipeline Review H1 2015 Market Research Report – New at ReportsnReports.com appeared first on Bigger Muscles Now.

from WordPress http://ift.tt/16eidBD

via IFTTT